Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLHL14 Activators

KLHL14, or Kelch-like protein 14, is a member of the Kelch-like (KLHL) family of proteins and is encoded by the KLHL14 gene in humans. This protein family is characterized by the presence of a Kelch repeat domain, which typically consists of a series of five to seven Kelch motifs that form a β-propeller tertiary structure. This structure is known to mediate protein-protein interactions and is involved in diverse cellular functions.The KLHL14 protein, like its family members, is also predicted to have a BTB/POZ domain in addition to the Kelch domain. The BTB/POZ domain is involved in protein dimerization and interaction with the Cullin 3 (Cul3) class of ubiquitin ligases, suggesting that KLHL14 might play a role in the ubiquitination pathway-a critical mechanism for protein degradation and regulation within the cell.

While the exact physiological functions of KLHL14 remain to be fully elucidated, proteins in the KLHL family are generally implicated in a variety of biological processes, including cytoskeletal organization, cell morphology, and the regulation of signal transduction pathways. Given its structural features, KLHL14 may be involved in similar processes, potentially serving as an adaptor that brings specific substrate proteins to the Cul3 ubiquitination complex, thereby targeting them for degradation.Studies of KLHL14 often focus on tissue-specific expression, the identification of its substrate proteins, and its role in ubiquitin-mediated proteolysis. Insights into these areas could reveal the underlying mechanisms by which KLHL14 influences cellular processes and contributes to the maintenance of cellular homeostasis.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor, potentially affecting ubiquitin-mediated protein degradation pathways involving KLHL14.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Another proteasome inhibitor, might impact protein degradation pathways relevant to KLHL14.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A selective proteasome inhibitor, could influence KLHL14-related processes.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Modulates the ubiquitin-proteasome system, potentially affecting KLHL14's role in protein ubiquitination.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Influences multiple signaling pathways, potentially impacting KLHL14.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, might influence cellular processes relevant to KLHL14's function.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Influences Wnt signaling, potentially intersecting with pathways involving KLHL14.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor, can impact gene expression and potentially KLHL14 function.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Alters DNA methylation, potentially impacting gene expression patterns relevant to KLHL14.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Influences histone acetylation, potentially affecting the expression of genes like KLHL14.